Bio-Rad Laboratories (BIO) Curent Deferred Tax Liability (2013 - 2014)
Bio-Rad Laboratories (BIO) reported Curent Deferred Tax Liability of $13.8 million for Q2 2014, up 45.49% on a QoQ basis from $9.5 million in Q4 2013.
Bio-Rad Laboratories (BIO) has 2 years of Curent Deferred Tax Liability data on file, last reported at $13.8 million in Q2 2014.
- Quarterly Curent Deferred Tax Liability changed N/A year-over-year to $13.8 million in Q2 2014, while the trailing twelve-month figure through Jun 2014 was $13.8 million (changed N/A YoY) and the FY2013 annual result came in at $9.5 million, changed N/A from the prior year.
- Curent Deferred Tax Liability rose to $13.8 million in Q2 2014 per BIO's latest filing, from $9.5 million in the prior quarter.
- Across five years, Curent Deferred Tax Liability topped out at $13.8 million in Q2 2014 and bottomed at $9.5 million in Q4 2013.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Curent Deferred Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Bio-Rad Laboratories | 8.23 Bn | 6.66 Bn | 309.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2014 | 13.76 Mn |
| Jun 30, 2014 | 13.76 Mn |
| Dec 31, 2013 | 9.45 Mn |
| Dec 31, 2013 | 9.45 Mn |